HEN Stock Analysis: Henkel & Co. KGaA | XETRA

Household & Personal Products | XETRA, Germany | Market Cap: 29.170m EUR | 12M Return: 12.3% | DE0006048408 | Charts, Fundamentals & Technical Analysis

Adhesives, Sealants, Hair Care, Detergents
Total Rating 57
Safety 83
Buy Signal 0.34
Household & Personal Products
Industry Rotation: +1.9
Market Cap: 32.5B
Avg Turnover: 4.12M
Risk 3d forecast
Volatility16.1%
VaR 5th Pctl2.62%
VaR vs Median-0.73%
Reward TTM
Sharpe Ratio0.51
Rel. Str. IBD60.3
Rel. Str. Peer Group32.4 pctl
Character TTM
Beta0.354
Beta Downside0.479
Hurst Exponent0.603
Choppyness67.7%
Drawdowns 3y
Max DD22.75%
CAGR/Max DD0.33
CAGR/Mean DD0.91

Warnings

No concerns identified

Tailwinds

Shakeout

Seasonality 11.7 years of data

Jan -2.4% 30
Feb -0.9% 18
Mar +0.2% 5
Apr +1.5% 19
May +0.7% 20
Jun -0.8% 19
Jul -0.3% 5
Aug +1.1% 18
Sep -1.2% 32
Oct -0.8% 14
Nov -0.2% 13
Dec -1.4% 0

How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.

Description: HEN Henkel & Co. KGaA

Henkel AG & Co. KGaA is a German multinational headquartered in Düsseldorf, founded in 1876, operating two main divisions: Adhesive Technologies and Consumer Brands. The Adhesive Technologies unit supplies adhesives, sealants, and functional coatings to sectors such as packaging, consumer goods, mobility, electronics, construction, and professional industries. The Consumer Brands unit spans hair styling, hair colorants, hair care, body care, laundry detergents, fabric softeners, dishwashing products, and household cleaners, with distribution through brick-and-mortar retail, salons, and digital channels. Henkel generated approximately $31.3 billion in market capitalization, classifying it as a large-cap stock within the GICS Consumer Staples sector, specifically the Personal Care Products sub-industry.

Headlines to Watch Out For
  • Adhesive Technologies margin expansion drives group profitability
  • Consumer Brands volume weakness persists amid private label competition
  • Raw material cost normalization supports gross margin recovery
Piotroski VR-10 (Strict) 6.0
Net Income: 1.91b TTM > 0 and > 6% of Revenue
FCF/TA: 0.06 > 0.02 and ΔFCF/TA -0.73 > 1.0
NWC/Revenue: 9.70% < 20% (prev 8.49%; Δ 1.21% < -1%)
CFO/TA 0.07 > 3% & CFO 2.71b > Net Income 1.91b
Net Debt (2.77b) to EBITDA (3.74b): 0.74 < 3
Current Ratio: 1.20 > 1.5 & < 3
Outstanding Shares: last quarter (405.4m) vs 12m ago -3.33% < -2%
Gross Margin: 51.32% > 18% (prev 50.28%; Δ 1.04% > 0.5%)
Asset Turnover: 59.00% > 50% (prev 64.58%; Δ -5.57% > 0%)
Interest Coverage Ratio: 26.53 > 6 (EBIT TTM 3.02b / Interest Expense TTM 114.0m)
Altman Z'' 4.52
A: 0.05 (Total Current Assets 11.9b - Total Current Liabilities 9.94b) / Total Assets 36.5b
B: 0.66 (Retained Earnings 24.0b / Total Assets 36.5b)
C: 0.09 (EBIT TTM 3.02b / Avg Total Assets 34.6b)
D: 1.36 (Book Value of Equity 21.0b / Total Liabilities 15.4b)
Altman-Z'' = 4.52 = AA
Beneish M -2.90
DSRI: 1.22 (Receivables 4.27b/3.63b, Revenue 20.4b/21.2b)
GMI: 0.98 (GM 50.28% / 51.32%)
AQI: 0.98 (AQ_t 0.56 / AQ_t-1 0.57)
SGI: 0.97 (Revenue 20.4b / 21.2b)
TATA: -0.02 (NI 1.91b - CFO 2.71b) / TA 36.5b)
Beneish M = -2.90 (Cap -4..+1) = A
What is the price of HEN shares?

As of October 29, 2026, the stock is trading at EUR 71.05 with a total of 116,425 shares traded. Over the past week, the price has changed by -0.63%, over one month by +3.57%, over three months by -1.46% and over the past year by +12.26%.

Current recommended Stop Loss: 68.40 (which is 3.7% or 2.4 ATR below the current price).

Is HEN a buy, sell or hold?

Henkel & Co. KGaA has no consensus analysts rating.

Henkel & Co. KGaA (HEN) - Fundamental Data Overview as of 27 October 2026
Market Cap USD = 32.5b (29.2b EUR * 1.11556 EUR.USD)
P/E Trailing = 15.3625
P/E Forward = 11.1359
P/S = 1.427
P/B = 1.3491
P/EG = 2.7854
Revenue TTM = 20.4b EUR
EBIT TTM = 3.02b EUR
EBITDA TTM = 3.74b EUR
Long Term Debt = 3.26b EUR (from longTermDebt, last quarter)
Short Term Debt = 2.83b EUR (from shortTermDebt, last quarter)
Debt = 6.76b EUR (from shortLongTermDebtTotal, last quarter) + Leases 666.0m
Net Debt = 2.77b EUR (calculated: Debt 6.76b - CCE 3.99b)
Enterprise Value = 31.9b EUR (29.2b + Debt 6.76b - CCE 3.99b)
Interest Coverage Ratio = 26.53 (Ebit TTM 3.02b / Interest Expense TTM 114.0m)
EV/FCF = 15.77x (Enterprise Value 31.9b / FCF TTM 2.02b)
FCF Yield = 6.34% (FCF TTM 2.02b / Enterprise Value 31.9b)
FCF Margin = 9.91% (FCF TTM 2.02b / Revenue TTM 20.4b)
Net Margin = 9.36% (Net Income TTM 1.91b / Revenue TTM 20.4b)
Gross Margin = 51.32% ((Revenue TTM 20.4b - Cost of Revenue TTM 9.95b) / Revenue TTM)
Gross Margin QoQ = 51.74% (prev 50.89%)
Tobins Q-Ratio = 0.88 (Enterprise Value 31.9b / Total Assets 36.5b)
Interest Expense / Debt = 1.69% (Interest Expense 114.0m / Debt 6.76b)
Taxrate = 24.77% (637.0m / 2.57b)
NOPAT = 2.28b (EBIT 3.02b * (1 - 24.77%))
Current Ratio = 1.20 (Total Current Assets 11.9b / Total Current Liabilities 9.94b)
Debt / Equity = 0.32 (Debt 6.76b / totalStockholderEquity, last quarter 21.0b)
Debt / EBITDA = 0.74 (Net Debt 2.77b / EBITDA 3.74b)
Debt / FCF = 1.37 (Net Debt 2.77b / FCF TTM 2.02b)
Total Stockholder Equity = 20.8b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.52% (Net Income 1.91b / Total Assets 36.5b)
RoE = 9.19% (Net Income TTM 1.91b / Total Stockholder Equity 20.8b)
RoCE = 12.56% (EBIT 3.02b / Capital Employed (Equity 20.8b + L.T.Debt 3.26b))
RoIC = 8.02% (NOPAT 2.28b / Invested Capital 28.4b)
WACC = 5.79% (E(29.2b)/V(35.9b) * Re(6.84%) + D(6.76b)/V(35.9b) * Rd(1.69%) * (1-Tc(0.25)))
Discount Rate = 6.84% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -88.49 | Cagr: -2.82%
[DCF] Terminal Value 75.22% ; FCFF base≈2.04b ; Y1≈2.02b ; Y5≈2.08b
[DCF] Fair Price = 117.2 (EV 32.5b - Net Debt 2.77b = Equity 29.7b / Shares 253.4m; r=8.35% [WACC [floored]]; 5y FCF grow -1.60% → 2.50% )
EPS Correlation: N/A | EPS CAGR: N/A | SUE: N/A | # QB: 0
Revenue Correlation: -88.89 | Revenue CAGR: -2.29% | SUE: 2.27 | # QB: 1
EPS current Year (2026-12-31): EPS=5.75 | Chg30d=-0.43% | Revisions=+25% | GrowthEPS=+8.2% | GrowthRev=+4.0%
EPS next Year (2027-12-31): EPS=6.17 | Chg30d=-2.68% | Revisions=+25% | GrowthEPS=+7.3% | GrowthRev=+5.9%
[Analyst] Revisions Ratio: +40% (up=2, down=0)